Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.
  • Hantavirus Outbreak
  • AI in Healthcare
  • Makary Resigns
  • Pancreatic Cancer Drug

WHAT'S NEW

  • RFK Jr.
  • Hantavirus Outbreak
  • AI in Healthcare
  • Makary Resigns
  • Pancreatic Cancer Drug

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Sep 10 2021

Full Issue

FDA Ban Decision Sends Market For 950,000 Vape Products Up In Smoke

Nearly a million vape product applications were rejected by the Food and Drug Administration on Thursday, banning the sale of them in the U.S. Technically, the FDA missed a court-ordered deadline to decide on all e-cigarette sales and has pushed a decision on big brands like Juul into the future.

Stat: FDA Misses Deadline For Deciding On E-Cigarette Products

The Food and Drug Administration announced Thursday that it has failed to meet a court-ordered deadline for deciding which e-cigarette products can stay on the market. In fact, it has yet to rule on whether any of the largest and most controversial e-cigarette companies, including JUUL, can keep selling their products. (Florko, 9/9)

The Wall Street Journal: FDA Needs More Time To Decide Fate Of Juul 

The Food and Drug Administration said it needed to take more time before deciding whether e-cigarettes made by Juul Labs Inc. and other top manufacturers can remain on the U.S. market. The FDA faced a Thursday deadline to respond to applications from Juul and other e-cigarette makers who had to submit their products for review to keep them on the U.S. market. The Wall Street Journal earlier reported that the FDA would take more time to reach a decision on Juul, the market leader. (Maloney, 9/9)

USA Today: FDA Delays Juul Decision, Rejects 950K Vaping Product Applications

The U.S. Food and Drug Administration on Thursday banned the sale of hundreds of thousands of vaping and electronic cigarette products, but delayed its decision on the industry's leading company, Juul. The agency faced a court deadline to issue decisions on marketing applications from the vaping giant and hundreds of other companies after anti-tobacco groups successfully sued the agency to speed up its review. Regulators previously said they would prioritize Juul and a handful of other key players, but none were included in the agency's announcement. (Rodriguez, 9/9)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF